Neglected Tropical Disease Treatment Market Size, Share, Trends, Growth Outlook

Neglected Tropical Disease Treatment Market is estimated to increase at a growth rate of 4.7% CAGR over the forecast period from 2024 to 2030.

The global Neglected Tropical Disease Treatment Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Disease (Dengue, Rabies, Trachoma, Buruli ulcer, Yaws, Leprosy, Chagas disease, Human African trypanosomiasis, Leishmaniases, Soil-transmitted helminthiases, Others), By Product (Drugs, Vaccines).

An introduction to Neglected Tropical Disease Treatment Market in 2024

Addressing the burden of neglected tropical diseases (NTDs), the Neglected Tropical Disease Treatment market offers therapeutic interventions targeting a group of infectious diseases prevalent in low-income and tropical regions. NTDs such as malaria, dengue fever, Chagas disease, and leishmaniasis affect millions of people worldwide, often causing chronic disability and socioeconomic hardship. Treatment modalities include antiparasitic drugs, antibiotics, and vaccines, supported by public health initiatives, international partnerships, and advocacy efforts to combat NTDs. The market's growth is driven by increasing awareness of NTDs, expanded access to essential medicines, and research investments in novel therapeutics and preventive strategies targeting neglected diseases.

Neglected Tropical Disease Treatment Market Trend: Increased Focus on Global Health Equity and Access

A significant trend in the neglected tropical disease (NTD) treatment market is the increased focus on global health equity and access. Neglected tropical diseases disproportionately affect marginalized populations in low- and middle-income countries, often resulting in significant morbidity, disability, and socioeconomic burden. There is a growing recognition of the need for concerted efforts to address these diseases and improve access to affordable and effective treatments for affected populations. This trend is driving collaborations between governments, non-profit organizations, and pharmaceutical companies to develop innovative treatment strategies, increase funding for NTD programs, and expand access to essential medicines, ultimately aiming to reduce the burden of NTDs and promote health equity worldwide.

Neglected Tropical Disease Treatment Market Driver: Rising Awareness and Advocacy Efforts

The primary driver propelling the neglected tropical disease treatment market is the rising awareness and advocacy efforts. Advocacy campaigns and initiatives led by international organizations, non-governmental organizations, and community-based groups have played a crucial role in raising awareness about NTDs, mobilizing resources, and advocating for increased investment in research, development, and access to treatments. Additionally, partnerships between public and private sectors, such as the World Health Organization's Neglected Tropical Diseases Roadmap and initiatives like the London Declaration on Neglected Tropical Diseases, have catalyzed efforts to combat NTDs by fostering collaboration, coordination, and resource mobilization. This driver underscores the importance of sustained advocacy efforts in driving policy changes, securing funding, and advancing research and development initiatives to address neglected tropical diseases effectively.

Neglected Tropical Disease Treatment Market Opportunity: Development of Novel Therapies and Combination Treatments

An exciting opportunity in the neglected tropical disease treatment market lies in the development of novel therapies and combination treatments. While existing treatments for NTDs have made significant strides in reducing morbidity and mortality, challenges such as drug resistance, treatment failure, and limited efficacy persist. There is a need for innovative approaches, including the development of new drug candidates with novel mechanisms of action, repurposing existing drugs for NTD indications, and exploring combination therapies to enhance treatment outcomes and address emerging challenges. Additionally, advancements in technologies such as drug delivery systems and biomaterials offer opportunities to improve the effectiveness, safety, and administration of NTD treatments. By investing in research and development initiatives focused on novel therapies and combination treatments, pharmaceutical companies can capitalize on this opportunity to address unmet medical needs, improve patient outcomes, and contribute to the global effort to eliminate neglected tropical diseases.

Neglected Tropical Disease Treatment Market Market Segmentation

By Disease
Dengue
Rabies
Trachoma
Buruli ulcer
Yaws
Leprosy
Chagas disease
Human African trypanosomiasis
Leishmaniases
Soil-transmitted helminthiases
Others
By Product
Drugs
Vaccines

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Neglected Tropical Disease Treatment Market Companies

Astellas Pharma Inc
Bayer AG
Eisai Co. Ltd
F. Hoffmann-La Roche Ltd
Gilead Sciences Inc
GlaxoSmithKline plc.
Merck KGaA
Novartis AG
Pfizer Inc
Sanofi
Takeda Pharmaceutical Company Ltd

Reasons to Buy the Neglected Tropical Disease Treatment Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Neglected Tropical Disease Treatment Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Neglected Tropical Disease Treatment Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Neglected Tropical Disease Treatment Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Neglected Tropical Disease Treatment Market Size Outlook, $ Million, 2021 to 2030
3.2 Neglected Tropical Disease Treatment Market Outlook by Type, $ Million, 2021 to 2030
3.3 Neglected Tropical Disease Treatment Market Outlook by Product, $ Million, 2021 to 2030
3.4 Neglected Tropical Disease Treatment Market Outlook by Application, $ Million, 2021 to 2030
3.5 Neglected Tropical Disease Treatment Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Neglected Tropical Disease Treatment Industry
4.2 Key Market Trends in Neglected Tropical Disease Treatment Industry
4.3 Potential Opportunities in Neglected Tropical Disease Treatment Industry
4.4 Key Challenges in Neglected Tropical Disease Treatment Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Neglected Tropical Disease Treatment Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Neglected Tropical Disease Treatment Market Outlook by Segments
7.1 Neglected Tropical Disease Treatment Market Outlook by Segments, $ Million, 2021- 2030
By Disease
Dengue
Rabies
Trachoma
Buruli ulcer
Yaws
Leprosy
Chagas disease
Human African trypanosomiasis
Leishmaniases
Soil-transmitted helminthiases
Others
By Product
Drugs
Vaccines

8 North America Neglected Tropical Disease Treatment Market Analysis and Outlook To 2030
8.1 Introduction to North America Neglected Tropical Disease Treatment Markets in 2024
8.2 North America Neglected Tropical Disease Treatment Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Neglected Tropical Disease Treatment Market size Outlook by Segments, 2021-2030
By Disease
Dengue
Rabies
Trachoma
Buruli ulcer
Yaws
Leprosy
Chagas disease
Human African trypanosomiasis
Leishmaniases
Soil-transmitted helminthiases
Others
By Product
Drugs
Vaccines

9 Europe Neglected Tropical Disease Treatment Market Analysis and Outlook To 2030
9.1 Introduction to Europe Neglected Tropical Disease Treatment Markets in 2024
9.2 Europe Neglected Tropical Disease Treatment Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Neglected Tropical Disease Treatment Market Size Outlook by Segments, 2021-2030
By Disease
Dengue
Rabies
Trachoma
Buruli ulcer
Yaws
Leprosy
Chagas disease
Human African trypanosomiasis
Leishmaniases
Soil-transmitted helminthiases
Others
By Product
Drugs
Vaccines

10 Asia Pacific Neglected Tropical Disease Treatment Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Neglected Tropical Disease Treatment Markets in 2024
10.2 Asia Pacific Neglected Tropical Disease Treatment Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Neglected Tropical Disease Treatment Market size Outlook by Segments, 2021-2030
By Disease
Dengue
Rabies
Trachoma
Buruli ulcer
Yaws
Leprosy
Chagas disease
Human African trypanosomiasis
Leishmaniases
Soil-transmitted helminthiases
Others
By Product
Drugs
Vaccines

11 South America Neglected Tropical Disease Treatment Market Analysis and Outlook To 2030
11.1 Introduction to South America Neglected Tropical Disease Treatment Markets in 2024
11.2 South America Neglected Tropical Disease Treatment Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Neglected Tropical Disease Treatment Market size Outlook by Segments, 2021-2030
By Disease
Dengue
Rabies
Trachoma
Buruli ulcer
Yaws
Leprosy
Chagas disease
Human African trypanosomiasis
Leishmaniases
Soil-transmitted helminthiases
Others
By Product
Drugs
Vaccines

12 Middle East and Africa Neglected Tropical Disease Treatment Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Neglected Tropical Disease Treatment Markets in 2024
12.2 Middle East and Africa Neglected Tropical Disease Treatment Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Neglected Tropical Disease Treatment Market size Outlook by Segments, 2021-2030
By Disease
Dengue
Rabies
Trachoma
Buruli ulcer
Yaws
Leprosy
Chagas disease
Human African trypanosomiasis
Leishmaniases
Soil-transmitted helminthiases
Others
By Product
Drugs
Vaccines

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Astellas Pharma Inc
Bayer AG
Eisai Co. Ltd
F. Hoffmann-La Roche Ltd
Gilead Sciences Inc
GlaxoSmithKline plc.
Merck KGaA
Novartis AG
Pfizer Inc
Sanofi
Takeda Pharmaceutical Company Ltd
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Disease
Dengue
Rabies
Trachoma
Buruli ulcer
Yaws
Leprosy
Chagas disease
Human African trypanosomiasis
Leishmaniases
Soil-transmitted helminthiases
Others
By Product
Drugs
Vaccines